SELECTIVE PARTIAL REDUCTION OF ESTERS USING GROUP IV TRANSITION METAL CATALYSTS AND USES THEREOF

APOL1 INHIBITORS AND METHODS OF USE

Apparatus and Process for the Automated Chemical Synthesis of Compounds

Perovskite-type compounds of formula ABX3

3-(benzylamino)-4-(cyclohexylamino)-n-(2-(piperazin-1-yl)ethyl)benzenesulfonamide derivatives and related ferrostatin-1 analogues as cell death inhibitors for treating e.g. stroke

Method for depleting 2-methoxyethanol (MOE)

Bioconjugation of polypeptides

Hydrogen sulfide donor in organic salt form and preparation method therefor

Method for the manufacturing of 2-(3-(alkyl and alkenyl)morpholino)-ethan-1-ols

PHARMACEUTICALLY ACCEPTABLE SALTS OF FATTY ACIDS

Immobilized ruthenium-triphos catalysts for selective hydrogenolysis of amides

Method for the manufacturing of 2-(3-(alkyl and alkenyl)morpholino)-ethan-1-ols

PVC plasticizers and methods for making thereof

Apparatus and process for the automated chemical synthesis of compounds

Dual NAV1.2/5HT2a inhibitors for treating CNS disorders

Energetic materials comprising perovskite compound ABX

Selective hydrogenation catalyst and selective hydrogenation method using the same

Synergistic compositions

Organo-1-oxa-4-azonium cyclohexane compounds

Organo-1-oxa-4-azonium cyclohexane compounds

Organo-1-oxa-4-azonium cyclohexane compounds

Pharmaceutically acceptable salts of fatty acids

Synergistic compositions

Salt forms of [R—(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-hepatonic acid

NOVEL RUTHENIUM COMPLEXES AND THEIR USES IN PROCESSES FOR FORMATION AND/OR HYDROGENATION OF ESTERS, AMIDES AND DERIVATIVES THEREOF

Catalytic hydrogenation for producing amines from carboxylic acid amides, carboxylic acid diamides, di-, tri-, or polypeptides, or peptide amides

Catalytic hydrogenation for the preparation of amines from amide acetals, ketene N, O-acetals or ester imides

Salt forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β, δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic-acid

Organo-1-oxa-4-azonium cyclohexane compounds

Compositions and methods for the treatment of multiple sclerosis

Synergistic compositions

Salt forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β, δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-hepatanoic acid

Pharmaceutically acceptable salts of fatty acids

Rhenium recovery from used reductive amination catalysts

AMINE SALTS OF PROSTAGLANDIN ANALOGS

Salt forms of [R-(R*,R*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid

SUBSTITUTED BENZYLAMINE COMPOUNDS, THEIR USE IN MEDICINE, AND IN PARTICULAR THE TREATMENT OF HEPATITIS C VIRUS (HCV) INFECTION

Catalysts and processes for the hydrogenation of amides

Salts of bicyclo-substituted pyrazolon azo derivatives, preparation method and use thereof

Process for preparing pyrrolidine

DIAMINE AND MEGLUMINE SALT FORMS OF FATTY ACIDS

Process for preparing piperazine

Salt forms of [R-(R*,R*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid

Process for preparing alkanolamines by homogeneously catalyzed alcohol amination

Process for preparing di-, tri- and polyamines by homogeneously catalyzed alcohol amination

Salts of bicyclo-substituted pyrazolon azo derivatives, preparation method and use thereof

Piperazine dithioctate and pharmaceutical composition comprising the same

Sphingosine kinase inhibitors

CORROSION INHIBITORS

Salt forms of [R-(R*,R*)]-2-(4-fluorophenyl)-beta, alpha-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid

NOVEL WATER BASED PROCESS FOR THE PREPARATION OF SUBSTITUTED DIPHENYLMETHYL PIPERAZINES

Catalyst and process for preparing an amine

Spiro Compounds Useful as Antagonists of the H1 Receptor

CROSSLINKER FOR VULCANIZATION, PROCESS FOR ITS PREPARATION AND RUBBER PRODUCTS

Processes for continuous fractional distillation of mixtures comprising morpholine, monoaminodiglycol, ammonia and water

Method for the continuous separation of mixtures comprising morpholine (MO), monoaminodiglycol (ADG), ammonia and water by means of distillation

2-aryl-2-fluoropropanoic acids and derivatives and pharmaceutical compositions containing them

δ-amino-γ-hydroxy-ω-aryl-alkanoic acid amides

δ-amino-γ-hydroxy-ω-aryl-alkanoic acid amide compound

Use of 1,4-bis (3-aminoalkyl) piperazine derivatives in the treatment of neurodegenerative diseases

Salt forms of [R—(R*,R*)]-2-(4-fluorophenyl)-β, δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid

Protective barrier composition comprising reaction of phosphorous acid with amines applied to a substrate

Racemic separation of 2,6-trans-dimethymorpholine

Method for producing ethylene amines

Salt forms of [R-(R*,R*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid

Salt forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β, δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)Carbonyl]-1H-pyrrole-1-heptanoic acid

Sphingosine kinase inhibitors

Method for the continuous production of an amine

Organic compounds

Morpholine derivatives as norepinephrine reuptake inhibitors

Sphingosine kinase inhibitors

Polymerisation inhibitor

Direct synthesis of di-heteroatom containing cyclic organic compounds

Process for fractionating water-containing crude amine mixtures from amine synthesis